Thero2-01S22 in HER2-positive Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: Thero2-01S22|DRUG: Placebo|DRUG: Thero2-01S22|DRUG: Placebo
Sponsor: Institut de cancérologie Strasbourg Europe